Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation

Liver Transplantation

Volumn 20, Issue 4, 2014, Pages 437-445

  Jun, Mi Jung ^a   Shim, Ju Hyun ^a   Kim, So Yeon ^a   Seo, Nieun ^a   Kim, Kang Mo ^a   Lim, Young Suk ^a   Lee, Han Chu ^a   Yu, Eunsil ^a   Lee, Sung Gyu ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LIVER BIOPSY; LIVER FUNCTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; BIOPSY; BLOOD; BLOOD PRESSURE; LIVER; LIVER FAILURE; MICROCIRCULATION; MIDDLE AGED; PATHOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; ALANINE TRANSAMINASE; BIOPSY; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, LDL; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MICROCIRCULATION; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 84897115768     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23832     Document Type: Article

References (33)

1. Brandhagen D, Fidler J, Rosen C,. Evaluation of the donor liver for living donor liver transplantation. Liver Transpl 2003; 9 (suppl 2): S16-S28.
2. Fan ST,. Live donor liver transplantation in adults. Transplantation 2006; 82: 723-732.
3. Pomfret EA, Pomposelli JJ, Jenkins RL,. Live donor liver transplantation. J Hepatol 2001; 34: 613-624.
4. Selzner M, Clavien PA,. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 2000; 31: 35-42.
5. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 1246-1251.
6. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 1993; 55: 807-813.
7. D'Alessandro AM, Kalayoglu M, Sollinger HW, Hoffmann RM, Reed A, Knechtle SJ, et al. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc 1991; 23 (pt 2): 1536-1537.
8. Rinella ME, Alonso E, Rao S, Whitington P, Fryer J, Abecassis M, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001; 7: 409-414.
9. Busuttil RW, Tanaka K,. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651-663.
10. Hwang S, Lee SG, Lee YJ, Sung KB, Park KM, Kim KH, et al. Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl 2006; 12: 920-927.
11. Ratziu V, Bugianesi E, Dixon J, Fassio E, Ekstedt M, Charlotte F, et al. Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. Aliment Pharmacol Ther 2007; 26: 821-830.
12. Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA,. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Clin Gastroenterol Hepatol 2007; 5: 1329-1332.
13. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al.; for LIDO Study Group. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906.
14. Ahn JS, Sinn DH, Gwak GY, Kim JM, Kwon CH, Joh JW, et al. Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy. Transplantation 2013; 95: 1404-1409.
15. Markin RS, Wisecarver JL, Radio SJ, Stratta RJ, Langnas AN, Hirst K, Shaw BW Jr,. Frozen section evaluation of donor livers before transplantation. Transplantation 1993; 56: 1403-1409.
16. Karcaaltincaba M, Akhan O,. Imaging of hepatic steatosis and fatty sparing. Eur J Radiol 2007; 61: 33-43.
17. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007; 47: 239-244.
18. Altman DG,. Practical Statistics for Medical Research. London, United Kingdom: Chapman and Hall; 1990.
19. Ryan CK, Johnson LA, Germin BI, Marcos A,. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002; 8: 1114-1122.
20. Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, Bass NM,. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006; 44: 874-880.
21. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023.
22. Gunneson TJ, Menon KV, Wiesner RH, Daniels JA, Hay JE, Charlton MR, et al. Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. Am J Gastroenterol 2002; 97: 1472-1475.
23. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD,; for American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009; 49: 1017-1044.
24. Beavers KL, Sandler RS, Fair JH, Johnson MW, Shrestha R,. The living donor experience: donor health assessment and outcomes after living donor liver transplantation. Liver Transpl 2001; 7: 943-947.
25. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F,. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009; 51: 433-445.
26. Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF,. Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol 2010; 16: 1560-1566.
27. Reeder SB, Cruite I, Hamilton G, Sirlin CB,. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34: 729-749.
28. Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013; 58: 1930-1940.
29. Sherlock S,. Acute fatty liver of pregnancy and the microvesicular fat diseases. Gut 1983; 24: 265-269.
30. Fromenty B, Berson A, Pessayre D,. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 1997; 26 (suppl 1): 13-22.
31. Shin YH, Ko JS, Kim GS, Gwak MS, Sim WS, Lee AR, et al. Impact of hepatic macrovesicular and microvesicular steatosis on the postoperative liver functions after right hepatectomy in living donors. Transplant Proc 2012; 44: 512-515.
32. Cheng YF, Chen CL, Lai CY, Chen TY, Huang TL, Lee TY, et al. Assessment of donor fatty livers for liver transplantation. Transplantation 2001; 71: 1221-1225.
33. Padoin AV, Mottin CC, Moretto M, Berleze D, Kupski C, Glock L, et al. A comparison of wedge and needle hepatic biopsy in open bariatric surgery. Obes Surg 2006; 16: 178-182.